EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, cilt.18, sa.14, ss.2076-2083, 2014 (SCI İndekslerine Giren Dergi)
Makale / Tam Makale
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
OBJECTIVE: Cisplatin (CP) is a popular chemotherapeutic agent. However, high doses of CP may lead to severe side effects to the gastrointestinal system. The aim of this study was to investigate the protective effects of infliximab on small intestine injury induced by high doses of CP.